1217 — China Innovation Investment Income Statement
0.000.00%
FinancialsSpeculativeMicro CapNeutral
- HK$128.02m
- -HK$9.14m
- -HK$2.07m
- 34
- 95
- 44
- 62
Annual income statement for China Innovation Investment, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 15.4 | 32 | -3.64 | -26.7 | -2.07 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.26 | 8.05 | 6.1 | 7.11 | -7.87 |
Operating Profit | 10.2 | 23.9 | -9.75 | -33.8 | 5.8 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 10.2 | 23.9 | -9.81 | -33.9 | 5.76 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.2 | 23.9 | -9.81 | -33.9 | 5.76 |
Net Income Before Extraordinary Items | |||||
Net Income | 10.2 | 23.9 | -9.81 | -33.9 | 5.76 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.2 | 23.9 | -9.81 | -33.9 | 5.76 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | 0.002 | -0.001 | -0.003 | 0 |